Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
04/2003
04/08/2003US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa
04/08/2003US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane
04/08/2003US6545015 Useful in therapy of bacterial infections, fungal infections
04/08/2003US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
04/08/2003US6544298 Dyeing human hair using coupler
04/08/2003CA2224983C Triazole antifungal agents
04/08/2003CA2109830C Lhrh antagonists and intermediate products
04/08/2003CA2097824C Functionalized vinyl azoles and their use
04/03/2003WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
04/03/2003WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
04/03/2003WO2002058632A3 Primary intermediates for oxidative coloration of hair
04/03/2003US20030065219 Cyclization of an alcohol containing urea compound
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065176 Anticoagulant; cardiovascular disorders
04/03/2003US20030065014 Substance for inducing apoptosis
04/03/2003US20030064984 Anticancer agents; side effect reduction
04/03/2003US20030064982 Pyrazole compounds useful as protein kinase inhibitors
04/03/2003US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease
04/02/2003EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen
04/02/2003EP0741694B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1407968A Adamantane derivatives
04/02/2003CN1104424C Triazolyl disulphides
04/02/2003CN1104419C Benzazepine derivatives with vasopressin agonistic activity
04/02/2003CN1104418C Benzoheterocyclic derivatives
04/01/2003US6541639 Efficient ligand-mediated Ullmann coupling of anilines and azoles
04/01/2003US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin.
04/01/2003US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/2003US6541499 Benzimidazole derivatives; e.g., 5-hydroxy-1-(3-methoxy-4-((1,2,4-triazol-1-yl)-methyl)benzyl) -2-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-benzimidazole
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
03/2003
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2002060879A3 Bacterial gyrase inhibitors and uses thereof
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060452 N-heterocyclic derivatives as NOS inhibitors
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294723A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294709A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1103770C Quino xaline diones
03/25/2003US6537986 Oxazolidinone antibacterial agents having a thiocarbonyl funtionality
03/20/2003WO2003022821A1 Heterocycle derivative having 20-hete-producing enzyme inhibitory activity
03/20/2003WO2003022812A1 Organic sulfates as ionic liquids
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives
03/20/2003US20030055055 For inducing and maintaining anesthesia, sedation and muscle relaxation, as well as for combating febrile convulsions in children
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055037 Benzimidazole and indole derivatives as CRF receptor modulators
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2460345A1 2-aroylimidazole compounds for treating cancer
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292577A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
03/19/2003EP1177192B1 Antifungal ethers
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP0900203B1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/13/2003WO2002096361A3 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050311 A novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles or benzoxazoles for treating neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amytrophic lateral sclerosis or cerebral trauma
03/13/2003US20030050254 Derivatives of erythromycin, their preparation process and their use as medicaments
03/13/2003US20030049287 Catechol oximes and their use in cosmetic and dermatological preparations
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531599 Compounds having activity as inhibitors of cytochrome P450RAI
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018543A1 Novel cyclohexyl sulphones
03/06/2003WO2003018135A1 Method of using 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase
03/06/2003US20030045715 Useful in treating and suppressing human Cytomegalovirus
03/06/2003US20030045528 Antibacterial and antiprotozoal agents
03/06/2003CA2456420A1 Novel cyclohexyl sulphones
03/05/2003EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
03/05/2003EP1286998A1 Oxazolidinone derivatives with antibiotic activity
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/05/2003CN1102592C 2R, 4S, S,S-and 2S, 4R, S,S-hydroxyitraconazole
03/04/2003US6528650 Cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing
03/04/2003US6528535 Bicyclic inhibitors of protein farnesyl transferase
03/04/2003US6528513 Viricides; especially cytomegalo virus
02/2003
02/27/2003WO2003016308A1 N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides
02/27/2003WO2003016276A2 3-substituted oxindole beta-3 agonists
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 163